Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 2 6Phase 4 3Phase 3 2Phase 1 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2009Carcinoma, Non-Small-Cell Lung 1222Breast Neoplasms 1214Leukemia, Myeloid, Acute 965Neoplasm Metastasis 900Melanoma 777Colorectal Neoplasms 749Lymphoma 725Multiple Myeloma 723Ovarian Neoplasms 673Pancreatic Neoplasms 664Prostatic Neoplasms 657Lymphoma, Non-Hodgkin 657Recurrence 636Precursor Cell Lymphoblastic Leukemia-Lymphoma 583Lung Neoplasms 559Leukemia, Lymphocytic, Chronic, B-Cell 555Glioblastoma 527Leukemia 485Lymphoma, Large B-Cell, Diffuse 440Lymphoma, Follicular 418Brain Neoplasms 413Squamous Cell Carcinoma of Head and Neck 388Stomach Neoplasms 386Carcinoma, Renal Cell 384Myelodysplastic Syndromes 381Carcinoma, Hepatocellular 367Advanced Solid Tumors 356Lymphoma, Mantle-Cell 345Glioma 342

Interventions

Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Interventional × Arthritis × Clear all
NCT07478679 2026-03-23

Radiation to Treat Joint Damage Caused by Cancer Immunotherapy

University of Chicago

Phase 1 Not yet recruiting
20 enrolled

Arthritis, Joint Diseases

NCT02144272 2015-07-17

Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis

Eli Lilly and Company

Phase 1 Completed
41 enrolled

Arthritis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡